166 related articles for article (PubMed ID: 26318844)
1. Critical role of phosphorylation of serine 165 of YBX1 on the activation of NF-κB in colon cancer.
Prabhu L; Mundade R; Wang B; Wei H; Hartley AV; Martin M; McElyea K; Temm CJ; Sandusky G; Liu Y; Lu T
Oncotarget; 2015 Oct; 6(30):29396-412. PubMed ID: 26318844
[TBL] [Abstract][Full Text] [Related]
2. Novel Serine 176 Phosphorylation of YBX1 Activates NF-κB in Colon Cancer.
Martin M; Hua L; Wang B; Wei H; Prabhu L; Hartley AV; Jiang G; Liu Y; Lu T
J Biol Chem; 2017 Feb; 292(8):3433-3444. PubMed ID: 28077578
[TBL] [Abstract][Full Text] [Related]
3. PRMT5-mediated methylation of YBX1 regulates NF-κB activity in colorectal cancer.
Hartley AV; Wang B; Mundade R; Jiang G; Sun M; Wei H; Sun S; Liu Y; Lu T
Sci Rep; 2020 Sep; 10(1):15934. PubMed ID: 32985589
[TBL] [Abstract][Full Text] [Related]
4. Targeting NF-κB RelA/p65 phosphorylation overcomes RITA resistance.
Bu Y; Cai G; Shen Y; Huang C; Zeng X; Cao Y; Cai C; Wang Y; Huang D; Liao DF; Cao D
Cancer Lett; 2016 Dec; 383(2):261-271. PubMed ID: 27721021
[TBL] [Abstract][Full Text] [Related]
5. The involvement of nuclear factor-kappa B in cyclooxygenase-2 overexpression in murine colon cancer cells transduced with herpes simplex virus thymidine kinase gene.
Konson A; Mahajna JA; Danon A; Rimon G; Agbaria R
Cancer Gene Ther; 2006 Dec; 13(12):1093-104. PubMed ID: 16841079
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of NF-kappaB activation and chemokine expression by the leukocyte glycoprotein, CD43, in colon cancer cells.
Laos S; Baeckström D; Hansson GC
Int J Oncol; 2006 Mar; 28(3):695-704. PubMed ID: 16465375
[TBL] [Abstract][Full Text] [Related]
7. Regulation of a PRMT5/NF-κB Axis by Phosphorylation of PRMT5 at Serine 15 in Colorectal Cancer.
Hartley AV; Wang B; Jiang G; Wei H; Sun M; Prabhu L; Martin M; Safa A; Sun S; Liu Y; Lu T
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456215
[TBL] [Abstract][Full Text] [Related]
8. Deletion of IκBα activates RelA to reduce acute pancreatitis in mice through up-regulation of Spi2A.
Neuhöfer P; Liang S; Einwächter H; Schwerdtfeger C; Wartmann T; Treiber M; Zhang H; Schulz HU; Dlubatz K; Lesina M; Diakopoulos KN; Wörmann S; Halangk W; Witt H; Schmid RM; Algül H
Gastroenterology; 2013 Jan; 144(1):192-201. PubMed ID: 23041330
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the wild-type p53 gene inhibits NF-kappaB activity and synergizes with aspirin to induce apoptosis in human colon cancer cells.
Shao J; Fujiwara T; Kadowaki Y; Fukazawa T; Waku T; Itoshima T; Yamatsuji T; Nishizaki M; Roth JA; Tanaka N
Oncogene; 2000 Feb; 19(6):726-36. PubMed ID: 10698490
[TBL] [Abstract][Full Text] [Related]
10. Suppression of RelA/p65 nuclear translocation independent of IkappaB-alpha degradation by cyclooxygenase-2 inhibitor in gastric cancer.
Wong BC; Jiang Xh; Fan XM; Lin MC; Jiang SH; Lam SK; Kung HF
Oncogene; 2003 Feb; 22(8):1189-97. PubMed ID: 12606945
[TBL] [Abstract][Full Text] [Related]
11. IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation.
Song YJ; Jen KY; Soni V; Kieff E; Cahir-McFarland E
Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2689-94. PubMed ID: 16477006
[TBL] [Abstract][Full Text] [Related]
12. Antiapoptotic effect of serum and glucocorticoid-inducible protein kinase is mediated by novel mechanism activating I{kappa}B kinase.
Zhang L; Cui R; Cheng X; Du J
Cancer Res; 2005 Jan; 65(2):457-64. PubMed ID: 15695387
[TBL] [Abstract][Full Text] [Related]
13. Dauricine induces apoptosis, inhibits proliferation and invasion through inhibiting NF-kappaB signaling pathway in colon cancer cells.
Yang Z; Li C; Wang X; Zhai C; Yi Z; Wang L; Liu B; Du B; Wu H; Guo X; Liu M; Li D; Luo J
J Cell Physiol; 2010 Oct; 225(1):266-75. PubMed ID: 20509140
[TBL] [Abstract][Full Text] [Related]
14. Nuclear Translocation of p65 is Controlled by Sec6 via the Degradation of IκBα.
Tanaka T; Iino M
J Cell Physiol; 2016 Mar; 231(3):719-30. PubMed ID: 26247921
[TBL] [Abstract][Full Text] [Related]
15. Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappaB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IkappaBalpha kinase activation.
Sung B; Pandey MK; Aggarwal BB
Mol Pharmacol; 2007 Jun; 71(6):1703-14. PubMed ID: 17387141
[TBL] [Abstract][Full Text] [Related]
16. Zeta isoform of protein kinase C prevents oxidant-induced nuclear factor-kappaB activation and I-kappaBalpha degradation: a fundamental mechanism for epidermal growth factor protection of the microtubule cytoskeleton and intestinal barrier integrity.
Banan A; Fields JZ; Zhang LJ; Shaikh M; Farhadi A; Keshavarzian A
J Pharmacol Exp Ther; 2003 Oct; 307(1):53-66. PubMed ID: 12893839
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells.
Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Sonenshein GE
Cancer Res; 2002 Nov; 62(22):6770-8. PubMed ID: 12438279
[TBL] [Abstract][Full Text] [Related]
18. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB
Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421
[TBL] [Abstract][Full Text] [Related]
19. Activation of NF-kappaB binding in HT-29 colon cancer cells by inhibition of phosphatidylinositol 3-kinase.
Wang Q; Kim S; Wang X; Evers BM
Biochem Biophys Res Commun; 2000 Jul; 273(3):853-8. PubMed ID: 10891336
[TBL] [Abstract][Full Text] [Related]
20. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
Duffey DC; Chen Z; Dong G; Ondrey FG; Wolf JS; Brown K; Siebenlist U; Van Waes C
Cancer Res; 1999 Jul; 59(14):3468-74. PubMed ID: 10416612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
